ClinicalTrials.Veeva
Menu

Find clinical trials for Triple Negative Breast Cancer in Rochester, MN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Breast Cancer
Non-Small-Cell Lung Carcinoma
Squamous Cell Carcinoma of Head and Neck
Ovarian Cancer
Cancer
Colorectal Cancer
Endometrial Cancer

Triple Negative Breast Cancer trials near Rochester, MN, USA:

Phase 1 Study of CLR 125 in Triple Negative Breast Cancer

The goal of this clinical trial is to evaluate the safety and efficacy of 3 different dose levels of CLR 125 in patients with advanced triple...

Enrolling
Breast Cancer
Drug: CLR 125
Drug: Iopofosine I 131

Phase 1

Cellectar Biosciences

Rochester, Minnesota, United States and 3 other locations

avelumab with sacituzumab govitecan works in treating patients with triple negative breast cancer that is stage I...

Active, not recruiting
Stage IIIA Breast Cancer
Recurrent Breast Carcinoma
Biological: Utomilumab
Biological: Anti-OX40 Antibody PF-04518600

Phase 2

Laura Huppert, MD, BA

Rochester, Minnesota, United States and 11 other locations

This is a Phase 3 trial to compare SRG-514 (active pharmaceutical ingredient \[API\]: ketorolac) administered intraoperatively to the tumor ...

Begins enrollment in 1 month
TNBC - Triple-Negative Breast Cancer
Procedure: BCS
Drug: BCS + SRG-514

Phase 3

SURGE Therapeutics

Rochester, Minnesota, United States and 2 other locations

or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...

Enrolling
Triple Negative Breast Cancer
Drug: Capecitabine
Drug: Sacituzumab govitecan-hziy (SG)

Phase 3

Gilead Sciences
Gilead Sciences

Rochester, Minnesota, United States and 356 other locations

(pembrolizumab) and chemotherapy for lymph node-positive, triple negative (TN) or hormone receptor positive/HER2-negative ...

Active, not recruiting
Hormone Receptor Positive (HR+), HER2-negative Breast Cancer
Triple Negative Breast Cancer
Drug: Paclitaxel
Drug: Carboplatin

Phase 2

Laura M. Spring, MD

Rochester, Minnesota, United States and 9 other locations

with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors...

Active, not recruiting
Triple Negative Breast Cancer
PD-L1 Positive
Drug: Pembrolizumab
Drug: Carboplatin

Phase 3

Gilead Sciences
Gilead Sciences

Rochester, Minnesota, United States and 506 other locations

The goal of this study is to test A2B395, an allogeneic logic-gated Tmod™ CAR T-cell product in subjects with solid tumors including colorec-...

Enrolling
Solid Tumor, Adult
Colon Cancer
Biological: A2B395
Diagnostic Test: xT CDx with HLA-LOH assay

Phase 1, Phase 2

A2 Biotherapeutics

Rochester, Minnesota, United States and 9 other locations

The goal of this clinical trial is to learn if the drug TUB-030 works to treat solid cancer in adults. The study will also explore the safet...

Enrolling
TNBC - Triple-Negative Breast Cancer
Advanced Solid Tumors
Drug: TUB-030

Phase 1, Phase 2

Tubulis

Rochester, Minnesota, United States and 15 other locations

pancreatic ductal adenocarcinoma (PDAC), non-small cell lung cancer (NSCLC), HR+/HER2- ductal and lobular breast cancer (B ...

Enrolling
HR+/HER2- Ductal and Lobular Breast Cancer
Non-small Cell Lung Cancer
Drug: [68Ga]Ga-NNS309
Drug: [177Lu]Lu-NNS309

Phase 1

Novartis
Novartis

Rochester, Minnesota, United States and 28 other locations

A Study of Emi-Le in Participants with Solid Tumors...

Enrolling
Endometrial Cancer
Breast Cancer
Drug: Emi-Le

Phase 1, Phase 2

Day One Biopharmaceuticals

Rochester, Minnesota, United States and 25 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems